If you would like more information about the profile please click
. You will be directed to a new page where you will need
to provide some information about yourself/your business cooperation needs and submit
your expression of interest in the profile . A Network Partner will then contact
you to discuss your interest in greater detail.
An Italian University spin-off is specialised in the study and analysis of biochemical, biophysical and structural features of proteins aiming at the development of inhibitors. This relates to drug design and downstream specific pharmaceutical processes. The small company is interested in technical cooperation agreements with R&D institutions and the pharmaceutical industry.
The Italian biotech company was founded in 2014 as a spin-off of the Department of Pharmaceutical Sciences at the University of Piemonte Orientale in Novara by a group of ambitious young biologists and bioengineers.
The company operates in the field of protein science. More in details, the company provides products and services related to the production and functional characterization of proteins of interest, determining mainly the structure of those of pharmaceutical interest to draw the development of inhibitors.
The company thus provides solutions in the field of protein science, structural biology and drug design for the production of target proteins, their biochemical and biophysical characterisation, and their structural analysis using X-ray crystallography, as hereafter listed:
- Protein production and purification
- Protein biochemical and biophysical profiling
- Assay development
- X-ray protein structural analysis
- Drug design and lead optimisation
Its services and expertise include in silico drug design, lead optimisation and small molecule XRD for absolute structure elucidation for the following market applications:
- Life science
- Enabling technologies
- Medical Research
The company is looking for partners - pharmaceutical companies, R&D, Universities and labs - interested in the effective, rational, structure-based drug discovery and development involving proteins, to sign or technical cooperation agreements.
The activity includes the development and validation of methods for laboratory analysis and for process control; chemical, physico-chemical, biological, technological and biotechnology; research, development and production of new molecules and / or new active ingredients for industrial use.
It is the first Italian company offering scientific expertise and tools to the study and analysis of biochemical, biophysical and structural protein which are crucial to the efficiency and quality of specific processes of industrial interest and for basic and applied scientific research. It was awarded the first prize of the 2015 "inNOVazione" innovation award organized by "Fondazione Novara Sviluppo" (2nd edition).
It was invited as speaker at SMAU 2015 for the "Filarete Healthy Startups" meeting of the Startup Revolutionary Road project organized by Fondazione Filarete, a Microsoft and Fondazione Cariplo co-funded project.
The company offers services and scientific support to research projects and industrial activities where expertise in protein science and drug discovery are needed.
They are interested in getting in touch with:
- Pharmaceutical companies;
- Medical centres, laboratories and related R&D institutions.